Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03933280
Other study ID # 2019/3/25/9
Secondary ID
Status Completed
Phase Phase 2
First received
Last updated
Start date July 1, 2019
Est. completion date January 1, 2021

Study information

Verified date January 2021
Source Menoufia University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Topical anaesthesia of the eye for ophthalmologic procedures avoids pain and discomfort of local anaesthetic injection in the peribulbar or retrobulbar block so that patient comfortability is achieved. Sedation during topical anaesthesia of the eye is mostly required to achieve anxiolysis, amnesia and keeping the patient calm all through the procedure. In the present study, the investigators will investigate the effect of nalbuphine/dexmedetomidine versus nalbuphine/propofol on the sedation as a primary outcome, intra-operative, postoperative analgesia, vital signs, patient and surgeon satisfaction and side effects as secondary outcomes


Description:

In both groups, the patients will receive i.v. nalbuphine 50 μg/kg. Patients in group D, will receive an i.v. loading dose of dexmedetomidine 1 μg/kg over 10 min followed by a maintenance infusion of 0.5 μg/kg/h. Patients in group P, will receive a bolus i.v. dose of propofol 0.5 mg/kg followed by an infusion started at 0.025 mg/kg/min .If sedation score was <3, rescue sedation with boluses of midazolam 0.01 mg/kg will be given. If the patient complained of pain (Numerical verbal pain rating scale ≥3) during the surgery, i.v. fentanyl 50 μg will be given as an intra-operative rescue analgesic and the surgeon will be instructed to use additional topical local anaesthetic eye drops if appropriate. After the completion of surgery, all infusions will be stopped, and the patients will be shifted to the postanaesthetic care unit (PACU) to be monitored for 2 hours before discharge.


Recruitment information / eligibility

Status Completed
Enrollment 100
Est. completion date January 1, 2021
Est. primary completion date December 1, 2020
Accepts healthy volunteers No
Gender All
Age group 20 Years to 65 Years
Eligibility Inclusion Criteria: - Both genders, - 20 and 65 years, - American Society of Anesthesiologists (ASA) physical status I and II, - Scheduled for cataract extraction surgery under topical anaesthesia. Exclusion Criteria: - Known allergy to local anaesthetics, - Allergy to study drugs, - Second or third-degree heart block, - Alcohol or drug abuse - Morbid obesity, pregnant and lactating females, - Patients with severe cardiac, renal and hepatic disorders.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Nalbuphine
i.v. nalbuphine bolus of 50 µg/kg.
Propofol
A bolus i.v. dose of propofol 0.5 mg/kg followed by an infusion of 0.025 mg/kg/min
Dexmedetomidine
i.v. loading dose of dexmedetomidine 1 µg/kg over 10 min followed by a maintenance infusion of 0.5 µg/kg/h.
Benoxinate Hydrochloride 0.4% Eye Drops
Benoxinate hydrochloride 0.4% eye drops instilled twice, 5 minutes apart.

Locations

Country Name City State
Egypt Faculty of Medicine Cairo Shebin El-kom

Sponsors (1)

Lead Sponsor Collaborator
Menoufia University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Sedation score The degree of sedation assessed by Ramsay sedation score(1 = anxious, agitated, restless;2 = cooperative, oriented, tranquil; 3 = responds to commands only; 4 = brisk response to light glabellar tap or loud noise; 5 = sluggish response to light glabellar tap or loud noise; 6 = no response), score of (1) means inadequate sedation. Score (2 to 4) indicates acceptable sedation. Score (5) or (6) excessive sedation. perioperative
Secondary Heart rate Heart rate in beats/minutes perioperative
Secondary Mean arterial blood pressure Mean arterial blood pressure in mmHg perioperative
Secondary Oxygen saturation Arterial oxygen saturation as a percentage of the total haemoglobin perioperative
Secondary Analgesia Measured by Numerical Pain Rating scale where the patient verbally rates pain from 0 "no pain" to 10 "worst imaginable pain" perioperative
See also
  Status Clinical Trial Phase
Terminated NCT02573818 - Sedasys Post Approval Study Users Response to System Alarms N/A
Recruiting NCT01100554 - Upper Airway Collapsibility Evaluation in Different Sedative Levels by Sleep Endoscopy N/A
Terminated NCT00226785 - Dexmedetomidine for Continuous Sedation Phase 3
Completed NCT02518919 - Procedural Sedation And Analgesia in Children in the Emergency Department: The Role of Adjunct Therapies N/A
Enrolling by invitation NCT04172415 - Current Procedural Sedation Practices in a Canadian Community Emergency Department
Completed NCT01020643 - Closed-loop Sedation of Propofol for Patients Undergoing Spinal Anesthesia Phase 4
Completed NCT00318955 - Post-Marketing Clinical Study to Assess Efficacy and Safety of Dexmedetomidine in Post-Operative Patients Phase 4
Completed NCT04621526 - Monitored Anesthesia Care: Dexmedetomidine-Ketamine Versus Dexmedetomidine- Propofol For Chronic Subdural Hematoma Phase 1/Phase 2
Completed NCT03085563 - A Comparison of Intranasal Midazolam and Nitrous Oxide (N2O) Minimal Sedation for Minor Procedures in a Pediatric Emergency Department Phase 4
Completed NCT01873612 - Acute Ventilatory Response to Hypoxia During Sedation With Dexmedetomidine Compared to Propofol in Healthy Male Volunteers Phase 4
Not yet recruiting NCT03466242 - IN Dexmedetomidine for Procedural Sedation in Pediatric Closed Reductions for Distal Forearm Fractures Early Phase 1
Completed NCT02679781 - Nasal Versus Oral Midazolam Sedation in Routine Pediatric Dental Care N/A
Completed NCT03885427 - Analgo-Sedative Effects Of Oral, Or Nebulized Ketamine In Pre-schoolers Undergoing Elective Surgery. Early Phase 1
Completed NCT00452426 - Safety and Effectiveness of a Computer-Assisted Personalized Sedation (CAPS) Device for Propofol Delivery During Endoscopy Phase 3
Completed NCT00261599 - An Effectiveness and Safety Study of AQUAVAN® Injection (Fospropofol Disodium) for Sedation During Colonoscopy Phase 3
Completed NCT00641563 - Effects of Two Different Sedation Regimes on Auditory Evoked Potentials and Electroencephalogram (EEG) N/A
Active, not recruiting NCT01118884 - Effects of Oral Midazolam in Comparison Promethazine With Nitrous Oxide for Uncooperative Children Phase 3
Terminated NCT00809380 - Parental Presence During Fracture Reduction in Children at the Emergency Department; A Randomized Controlled Trial N/A
Completed NCT03886454 - Incidence and Nature of Respiratory Impairment in Consecutive Patients Undergoing Bronchoscopy Under Conscious Sedation: A Pilot Study
Completed NCT03925779 - Conscious Sedation for Outpatient Colonoscopy Phase 2